Latest Prescription Drugs news
FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
posted October 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sotatercept Reduces Risk for Clinical Worsening in Adults With Recently Diagnosed PAH
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic, Bariatric Surgery
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Zoryve for Atopic Dermatitis in Young Children
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Frequent Cannabis Use Linked to Epilepsy Severity Monthly Specialist Briefings
Stay Connected
